New Key Statistics Module, Z-Score and F-Score
NAS:ASND Key Ratios
| Market Cap $ M | 7,891.31 |
| Enterprise Value $ M | 8,336.89 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 22.88 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 344.00 |
| EPS (TTM) $ | -9.31 |
| Beneish M-Score | -2.53 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -18.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -22.61 |
| EV-to-EBITDA | -23.04 |
| PEG | -- |
| Shares Outstanding M | 59.76 |
| Net Margin (%) | -153.32 |
| Operating Margin % | -110.40 |
| Pre-tax Margin (%) | -150.42 |
| Quick Ratio | 0.44 |
| Current Ratio | 0.74 |
| ROA % (ttm) | -59.82 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -68.89 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.84 |
ASND Number of Guru Trades
ASND Volume of Guru Trades
Gurus Latest Trades with NAS:ASND
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ASND is held by these investors
Total 2
Ascendis Pharma AS Insider Transactions
No Available Data
News about NAS:ASND
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers